IMGN Financial Facts
Clinical materials reimbursement: 46KResearch and development support: 1.35M
See Full Income Statement
Accrued compensation: 6.75M
Other assets: 3.13M
See Full Balance Sheet
Immunogen Inc. (IMGN) Earnings
|
Expand Research on IMGN
Next EPS Date | 4/25/24 *Est. | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +73.5% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +51.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
2/12/21 | Q420 | $0.16 | -$0.10 | +$0.26 | $85.8M | $37.09M | = | Details | |||
11/1/19 | Q319 | -$0.15 | -$0.18 | +$0.03 | $13.28M | $9.88M | = | Details | |||
2/14/20 | Q419 | $0.03 | -$0.05 | +$0.08 | $44.9M | $29.33M | = | Details | |||
4/28/23 | Q123 | -$0.16 | -$0.25 | +$0.09 | $49.9M | $20.97M | N/A | Details | |||
1/30/15 | Q215 | $0.16 | -$0.05 | +$0.21 | $48.3M | $37.3M | N/A | Details | |||
5/3/19 | Q119 | -$0.30 | -$0.20 | -$0.10 | $8.6M | $10.59M | = | Details | |||
7/28/17 | Q217 | -$0.10 | -$0.17 | +$0.07 | $39.02M | $30.6M | = | Details | |||
2/8/19 | Q418 | -$0.28 | -$0.32 | +$0.04 | $13.8M | $12.27M | = | Details |